Literature DB >> 15739262

Transendothelial migration of two metastatic breast carcinoma cells depend on the SDF-lalpha-CXCR4 complexes.

T Lechertier1, M Berard, R Vassy, M A Herve, M Crepin.   

Abstract

The role of the SDF-1alpha chemokine-CXCR4 receptor system on tumor cell transendothelial migration was studied by culturing metastatic breast tumor cell lines, MDA-MB-231 and MDA-MB-435, either alone or on a HUVEC monolayer pre-established on a "Transwell" filter. After a 24-hour culture in the presence or absence of SDF-1alpha, tumor cell transmigration rates were compared. We showed that: CXCR4 is present on both cell lines; MDA-MB-231 but not MDA-MB-435 cell migration is stimulated by increasing concentrations of SDF-1alpha; neutralizing anti-CXCR4 antibody inhibits the SDF-1alpha chemoattractant effect; CXCR4 expression, measured by cytofluorometry, was enhanced after treatment with SDF-1alpha on MDA-MB-231 cells but remained unchanged on MDA-MB-435 cells; Scatchard analysis evidences 8.10(5) and 2.10(5) high affinity sites (KD range: 20 to 30 nM) on, respectively, MDA-MB-231 and MDA-MB-435 cells. These significant differences could explain the distinctive transendothelial migration responses of these two cell lines in the presence of SDF-1alpha.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15739262

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Biomaterial-enabled delivery of SDF-1α at the ventral side of breast cancer cells reveals a crosstalk between cell receptors to promote the invasive phenotype.

Authors:  Xi Qiu Liu; Laure Fourel; Fabien Dalonneau; Rabia Sadir; Salome Leal; Hugues Lortat-Jacob; Marianne Weidenhaupt; Corinne Albiges-Rizo; Catherine Picart
Journal:  Biomaterials       Date:  2017-02-27       Impact factor: 12.479

2.  Transforming growth factor-beta1 upregulates the expression of CXC chemokine receptor 4 (CXCR4) in human breast cancer MCF-7 cells.

Authors:  Xiao-ping Zhao; Yong-yao Huang; Yu Huang; Ping Lei; Ji-lin Peng; Sha Wu; Min Wang; Wen-han Li; Hui-fen Zhu; Guan-xin Shen
Journal:  Acta Pharmacol Sin       Date:  2010-02-15       Impact factor: 6.150

Review 3.  Organ selectivity in metastasis: regulation by chemokines and their receptors.

Authors:  Adit Ben-Baruch
Journal:  Clin Exp Metastasis       Date:  2007-09-21       Impact factor: 5.150

4.  PDZ-RhoGEF is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA.

Authors:  Amanda P Struckhoff; Manish K Rana; Swapnil S Kher; Matt E Burow; Joseph L Hagan; Luis Del Valle; Rebecca A Worthylake
Journal:  J Cell Sci       Date:  2013-07-18       Impact factor: 5.285

5.  Topotecan inhibits cancer cell migration by down-regulation of chemokine CC motif receptor 7 and matrix metalloproteinases.

Authors:  Sen-sen Lin; Li Sun; Yan-kai Zhang; Ren-ping Zhao; Wen-lu Liang; Sheng-tao Yuan; Lu-yong Zhang
Journal:  Acta Pharmacol Sin       Date:  2009-04-13       Impact factor: 6.150

6.  A general method for site specific fluorescent labeling of recombinant chemokines.

Authors:  Tetsuya Kawamura; Bryan Stephens; Ling Qin; Xin Yin; Michael R Dores; Thomas H Smith; Neil Grimsey; Ruben Abagyan; Joann Trejo; Irina Kufareva; Mark M Fuster; Catherina L Salanga; Tracy M Handel
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

7.  Discovery and Optimization of N-Substituted 2-(4-pyridinyl)thiazole carboxamides against Tumor Growth through Regulating Angiogenesis Signaling Pathways.

Authors:  Wenbo Zhou; Wenshu Tang; Zhenliang Sun; Yunqi Li; Yanmin Dong; Haixiang Pei; Yangrui Peng; Jinhua Wang; Ting Shao; Zhenran Jiang; Zhengfang Yi; Yihua Chen
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

8.  CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration.

Authors:  Ke Zen; Dan-Qing Liu; Ya-Lan Guo; Chen Wang; Jun Shan; Ming Fang; Chen-Yu Zhang; Yuan Liu
Journal:  PLoS One       Date:  2008-03-19       Impact factor: 3.240

9.  Oridonin inhibits tumor growth and metastasis through anti-angiogenesis by blocking the Notch signaling.

Authors:  Yanmin Dong; Tao Zhang; Jingjie Li; Huayun Deng; Yajuan Song; Dong Zhai; Yi Peng; Xiaoling Lu; Mingyao Liu; Yongxiang Zhao; Zhengfang Yi
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.